Covance 公司簡介
Covance，總部在普林斯頓，新澤西，是世界上zui大和zui全面的藥物開發(fā)與服務(wù)公司。公司產(chǎn)品涉及免疫病理學(xué)、神經(jīng)系統(tǒng)學(xué)以及結(jié)構(gòu)蛋白與信號傳導(dǎo)等方面的相關(guān)抗體，在生物市場享有*的聲譽(yù)，服務(wù)對象遍布的大學(xué)、科研機(jī)構(gòu)和高新生物技術(shù)公司，年收入超過2億美元，員工遍布60多個國家，在有11000多名員工。
華雅干細(xì)胞主要在中國代理銷售BD、GE、Bio-Rad、NUNC、Nalgene、PALL、Axygen、Crystalgen等品牌的實驗耗材類產(chǎn)品；在中國代理銷售Roche、LONZA、BD、GE、Bio-Rad、VWR、Vigorous、Cygnus、ExCell、R&D、ALPCO、Amresco等生物試劑；Bio-Rad、HEROS、VWR等生物儀器，更多產(chǎn)品咨詢與購買！
重慶市華雅干細(xì)胞技術(shù)有限公司在倉庫備有現(xiàn)貨，歡迎新老客戶：
重慶市華雅干細(xì)胞技術(shù)有限公司在中國銷售Covance公司的產(chǎn)品
Covance Antibody Products
Our History
In 1998, Covance acquired the Berkeley Antibody Company (BAbCO), bringing scientists an outstanding catalog of ready-to-use antibody products, including leading epitope tag antibodies such as HA.11/16B12, 9E10 and AU1/AU5. The antibody products catalog also includes a collection of well characterized tools in the areas of cell and organelle markers, cytoskeletal components, and cytokeratins. Covance has continued to expand its line of antibody products, by selecting the best antibodies through collaboration with researchers, licensing and commercialization from university laboratories, and acquisition of promising commercial product lines.In 2005, Covance acquired the gold-standard SMI® antibodies for neuroscience via the purchase of Sternberger Monoclonals, Inc. These well-regarded markers and immunohistochemistry detection reagents include the SMI-31 and SMI-32 monoclonals against neurofilaments and key antibodies fordetecting myelin, GFAP and SNAP/SNARE components.
In May 2006, Covance positioned itself as the leading provider of neuroscience antibody products when it acquired key assets of Signet Laboratories, Inc. Signet’s industry-leading antibodies include the monoclonal antibodies 6E10 & 4G8 to beta amyloid and new BetaMark™ ELISA assays for beta amyloid and APP processing, part of a suite of tools at the forefront of Alzheimer’s and neurodegenerative disease research. The Covance catalog has also been enriched by Signet’s outstanding line of anatomic pathology and oncology antibodies, including breast cancer and ovarian cancer markers such as BRST-2, D2-40 and HE4. The Covance antibody division is now aligned with Covance’s discovery services group to continue to expand into promising endeavors that empower drug development and discovery research. If your next antibody, vaccine, or business development project fits into hat future, contact us.
Covance 公司主要產(chǎn)品分類如下：
1、Epitope tag & fusion 表位標(biāo)記相關(guān)抗體
2、Neuroscience神經(jīng)系統(tǒng)學(xué)
2.1、Neurodegenerative Disease 神經(jīng)性疾病研究相關(guān)抗體
2.2、Neuronal Markers 神經(jīng)元相關(guān)抗體
2.3、Neuroscience Signaling 神經(jīng)信號相關(guān)抗體
3、Signet Immunopathology免疫病理學(xué)
3.1、Immunopathology antibody 免疫相關(guān)抗體
3.2、Immunopathology Detection Reagents & Ancillaries 免疫檢測試劑與輔助設(shè)備
4、Structural Proteins & Cell Components 結(jié)構(gòu)蛋白及其相關(guān)產(chǎn)品抗體
4.1、cytokeratins 細(xì)胞角蛋白相關(guān)抗體
4.2、cytoskeleton細(xì)胞骨架相關(guān)抗體
4.3、Organelles & Subcellular 細(xì)胞器與亞細(xì)胞相關(guān)抗體
5、signal transduction & gene exprssion 信號轉(zhuǎn)導(dǎo)與基因表達(dá)相關(guān)抗體
6、Detection Reagents 檢測試劑產(chǎn)品
7、Signet Antibodies Signet 抗體產(chǎn)品總匯
7.1、Neuroscience神經(jīng)系統(tǒng)學(xué)相關(guān)抗體
7.2、Oncology/Immunopathology 腫瘤研究相關(guān)抗體
7.3、Multidrug Resistance（MDR) 耐藥性研究相關(guān)抗體
7.4、Blood Group Antigens 血型抗原
7.5、Renal Panel 腎臟研究相關(guān)抗體
7.6、Detection Reagents 相關(guān)檢測試劑
8、SIM Monoclonals SIM單克隆抗體產(chǎn)品
9、customer services 服務(wù)
9.1、Biotechnology Services
9.2、Immunology Services
9.3、Clinical Services
9.4、Biorepository Services
